FERA Diagnostics And Biologicals Announces Key Hires

Heath Landis and Jeff Baxter, recognized sales and marketing leaders in the U.S. animal health industry, will support the adoption of the synthetic analog FerAppease in beef and dairy.

beef dairy cross
beef dairy cross
(Alison Fulton)

FERA Diagnostics & Biologicals announces it has hired Heath Landis and Jeff Baxter to support the marketing and use of FerAppease, a synthetic analog, designed to reduce stress in beef and dairy cattle.

As the U.S. National Sales Director for FERA, Landis will lead sales force engagement with distribution partners, veterinarians and their beef and dairy producer clientele to position the use of FerAppease in reducing stress in their cattle during times of handling, transportation and commingling.

With over 25 years in the animal health industry and previous sales and leadership experience with MULTIMIN USA/Axiota Animal Health, Landis has built strong relationships with key distributor partners, bovine veterinarians and producers in all segments of the beef and dairy industries.

Baxter has 20 years of science-focused marketing experience with multi-national animal health companies and diagnostic startups all focused on the bovine industry assuming the role of Marketing Director for FERA.

Most notably launching the Vista vaccine line for Intervet Inc. (now Merck Animal Health), Baxter collaborated with technical service peers and the research and development team to define new expectations with bovine veterinarians regarding the understanding of immunology and vaccinology.

Launched in 2022 by FERA, FerAppease is a synthetic analog of the active ingredient Maternal Bovine Appeasing Substance (MBAS). MBAS is a naturally occurring substance that is secreted by the skin of the mammary gland of lactating animals, reducing stress in cattle treated. To use FerAppease, no veterinarian prescription nor Veterinary Feed Directive plan is required, and there are no meat or milk withholding requirements.

FERA Diagnostics & Biologicals is a privately held animal health company based in College Station, Texas. Combining innovation and science, FERA has introduced FerAppease to address the hidden health and economic costs of stress on cattle. For more information, visit www.feraah.com.

More news from Bovine Veterinarian:

Next-Gen DVMs Share Their Best Practice Tips
New Diagnostic Program Developed for Feedlot Employees
Choline: A Transition Staple that Helps Calves, Too

Read Next
After nearly 14 years without foot-and-mouth disease, Europe faced multiple unrelated incursions in 2025 and 2026. Rapid detection, regionalization and vaccine readiness helped contain the virus and offered lessons for animal health professionals worldwide.
Follow Bovine Veterinarian
Get News Weekly
Get Markets Alerts
Get News & Markets App